Furthermore, in clinically affected patients with heterozygous variants in COL4A3, COL4A4 an increased risk of progression to chronic renal failure was observed in up to 38% and a progression to ESRD was observed in up to 20% (15). Here, COL4A3 is linked to chronic kidney disease.